AREVO Unveils First 3D-Printed Carbon-Fiber eBike
Company debuts its second application with OECHSLER and unlocks the global manufacturing power of its 3D-printing process
SANTA CLARA, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- AREVO®, the leader in software-controlled additive manufacturing technology, today announced the launch of its eBike - the world's first battery-assisted bike using a 3D carbon fiber frame. On the heels of launching the first 3D printed all terrain city bike in May, AREVO's eBike is another real-world example of the company's capabilities and time savings that come with its one-of-a-kind, 3D printing process.
AREVO's 3D printing process combines software, robotics, machine learning and thermoplastic materials to provide designers and manufacturers with unprecedented freedom to create products with unparalleled strength and durability. As a result, AREVO's eBike can be customized for individual riders, printed as and when needed at scale, and competitively manufactured anywhere in the world.
"We have created a new paradigm for manufacturing that empowers businesses to create and source products locally by leveraging advancements in dynamic software and automation," said Jim Miller, CEO of AREVO. "The development of the eBike has proven that we can 3D print a new product when needed, at a low cost and localize the manufacturing process - significantly cutting down on the process and time it has taken historically to create bike frames."
AREVO partnered with OECHSLER, a manufacturer mainly for automotive and medical parts, to leverage their DRIVEMATIC three-speed automatic gearbox with AREVO's 3D printed carbon fiber frame for an electric 3D printed bike. The bike has a unique feature set ideal for the modern bike commuter including Bluetooth capability and smartphone connectivity to easily track bike data like battery life, current speed and distance.
"We're committed to being at the forefront of manufacturing innovation, and partnering with AREVO allowed us to explore a unique use case for our integrated drive system," said Michael Oppermann, Director Business Development, from OECHSLER. "With AREVO'S ability to quickly produce custom bike frames, we'll be able to meet the increasing demand for eBikes at a fraction of the time, cost and environmental impact of the standard bike production process."
For more on AREVO"s technology and to follow future applications, visit http://www.arevoinc.com/.
AREVO, based in Santa Clara, California, develops technology to enable direct digital additive manufacturing of ultra-strong, lightweight composite parts for end use applications in high volume. With our unique combination of breakthrough materials, powerful design/build software, and free motion robotics for the first "true 3D" construction, AREVO is moving beyond prototypes by enabling the design and fabrication of large, mass-produced parts and structures to happen anywhere, quickly leading 3D printing into mainstream manufacturing. AREVO provides designers and manufacturers with unprecedented freedom to unlock the unparalleled strength and weight of composite materials for a wide range of consumer and industrial products, and has seen early success manufacturing CFRTP composite parts for OEM customers. With an initial focus on Aerospace, Defense, Consumer Electronics, Transportation, and Consumer Goods, Arevo is poised to optimize additive manufacturing services to OEM's worldwide. For more information visit http://www.arevoinc.com/.
Meredith Klee for AREVO
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Arevo Inc. via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
David Crosby Announces Intent to License His Name to the Cannabis Industry18.7.2018 18:04 | Pressmeddelande
Music industry icon pursuing licensing partnership with a leading Cannabis company LOS ANGELES and TORONTO, July 18, 2018 (GLOBE NEWSWIRE) -- David Crosby, co-founder of two of the most successful bands in history (Crosby, Stills, Nash & Young, and The Byrds) today announced he is seeking a licensing relationship with a national or global Cannabis company. This opportunity would include the exclusive license of his iconic name and marks for use worldwide. Mr. Crosby suggests calling the brand "MIGHTY CROZ" because his friends, colleagues and fans call him "Croz", but specific naming and packaging will be determined in consultation with the selected Cannabis company. Mr. Crosby will actively advise the selected Cannabis company in developing and marketing the brand. "People have been asking me to do a quality Cannabis brand and with legalization expanding, now is the right time," said David Crosby from his ranch in California. "Our first priority is partnering with a leading Cannabis co
Telecom Argentina's landing station and backhaul are selected for ARBR submarine cable system between Argentina & Brazil18.7.2018 17:00 | Pressmeddelande
ARBR + Seabras-1 to provide most direct route between Buenos Aires & New York BUENOS AIRES, Argentina and BOSTON, July 18, 2018 (GLOBE NEWSWIRE) -- Telecom Argentina S.A. ("Telecom Argentina") (BASE:TECO2) (NYSE:TEO), one of Argentina's leading telecommunications companies, Grupo Werthein, a preeminent Argentine investment holding company with a track record of significant telecommunications holdings, and Seaborn Networks ("Seaborn"), a leading developer-owner-operator of submarine fiber optic cable systems, announced today that the ARBR submarine cable system between Argentina and Brazil ("ARBR") will be landing in Telecom Argentina's cable landing station in Las Toninas, Argentina. In addition, Telecom Argentina shall provide ARBR with dark fiber on a backhaul route between Las Toninas and Buenos Aires, as well as point of presence (POP) space in Buenos Aires. ARBR is a new fiber optic submarine cable system developed by Seaborn and co-owned by Seaborn's Seabras Group together with T
Salim Ismail Announced as Keynote Speaker at Mitratech's Interact 2018 Conference18.7.2018 15:02 | Pressmeddelande
Best-Selling Author and Tech Strategist Shares Insights on New Paradigm in Organizational Design AUSTIN, Texas, July 18, 2018 (GLOBE NEWSWIRE) -- Mitratech, the leading provider of legal and compliance software solutions, today announced that Salim Ismail, best-selling author, founding executive director of Singularity University, and founder of ExO Works, will deliver the keynote address at its Interact 2018 Conference. Every year the Interact conference provides an opportunity for clients, industry experts and partners to connect, learn, and contribute to insightful sessions on Mitratech innovations, legal operations best practices and industry trends. This year's theme, The Next Frontier of Legal Ops, recognizes that legal operations should be a center of innovation and excellence that brings people, processes and information together like never before by extending legal operations capabilities across the entire enterprise. "Salim understands the power of innovation and technology t
Corvil Introduces AI-Powered "Intelligence Hub" to Help Businesses Achieve Superior Digital Experiences and Performance18.7.2018 15:00 | Pressmeddelande
The solution delivers powerful big data analytics insights to business and operational users without the traditional lengthy timelines and costs DUBLIN, Ireland, July 18, 2018 (GLOBE NEWSWIRE) -- Corvil today announced Intelligence Hub, the next generation of digital intelligence to improve the performance, agility and digital experience of today's modern businesses. Intelligence Hub offers the potential to dramatically change how organizations see, manage and optimize their business and supporting technology operations. Today's businesses require a new type of "digital intelligence" that understands and correlates changes in the critical dimensions of business outcomes, user and customer experience, underlying application and infrastructure performance, and cybersecurity. Intelligence Hub provides proactive alerting on changes in these dimensions and allows business and operations teams to flexibly visualize, explore and analyze this key information for more informed action. " Intelli
Taconic Biosciences and Cyagen Biosciences Announce Strategic Partnership18.7.2018 14:00 | Pressmeddelande
RENSSELAER, N.Y., July 18, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences and Cyagen Biosciences, global leaders in the generation of custom genetically engineered rodent models and associated services, announced a strategic partnership. Under the agreement terms, the two companies will combine resources to provide the global scientific community with access to premium custom model design and generation services backed by comprehensive capabilities and cutting-edge, fully-licensed technologies. Custom animal models play a critical role in new drug discovery as biological systems that provide critical insight into the dynamic between a potential therapeutic and a living organism. Combining over twenty years of experience, the industry's most extensive model generation technology portfolio, and seamless integration to downstream premium custom breeding solutions, Taconic is recognized for creating complex genetically engineered mice and rats for biomedical research. Cyagen entered the indu
Data to be Presented From Biogen's Alzheimer's Disease Clinical Development Portfolio at the 2018 Alzheimer's Association International Conference (AAIC)18.7.2018 13:30 | Pressmeddelande
Ongoing Alzheimer's disease research programs target possible causes of the disease through multiple modalities Data to be presented from Alzheimer's disease clinical development portfolio including aducanumab, elenbecestat, and BAN2401 Data underscore Biogen's long-term commitment to furthering Alzheimer's disease research and treatment, with a focus on patients with early stage disease CAMBRIDGE, Mass., July 18, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq:BIIB) announced it will present data from its Alzheimer's disease clinical development portfolio at the upcoming Alzheimer's Association International Conference (AAIC) in Chicago (July 22-26). Data being presented are part of Biogen's research programs targeting several of the identified causes of Alzheimer's disease, focusing on early-stage disease. "The data to be presented at AAIC exemplify our belief that treatments are needed at the earliest stages of Alzheimer's disease to impact the underlying pathophysiology and delay disease p
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum